91 related articles for article (PubMed ID: 15778422)
1. Effect of the MDR1 C3435T variant and P-glycoprotein induction on dicloxacillin pharmacokinetics.
Putnam WS; Woo JM; Huang Y; Benet LZ
J Clin Pharmacol; 2005 Apr; 45(4):411-21. PubMed ID: 15778422
[TBL] [Abstract][Full Text] [Related]
2. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
Pauli-Magnus C; Feiner J; Brett C; Lin E; Kroetz DL
Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
[TBL] [Abstract][Full Text] [Related]
3. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
[TBL] [Abstract][Full Text] [Related]
4. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
[TBL] [Abstract][Full Text] [Related]
6. Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene.
Johne A; Köpke K; Gerloff T; Mai I; Rietbrock S; Meisel C; Hoffmeyer S; Kerb R; Fromm MF; Brinkmann U; Eichelbaum M; Brockmöller J; Cascorbi I; Roots I
Clin Pharmacol Ther; 2002 Nov; 72(5):584-94. PubMed ID: 12426522
[TBL] [Abstract][Full Text] [Related]
7. Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells.
Calado RT; Falcão RP; Garcia AB; Gabellini SM; Zago MA; Franco RF
Haematologica; 2002 Jun; 87(6):564-8. PubMed ID: 12031911
[TBL] [Abstract][Full Text] [Related]
8. Impact of P-glycoprotein on clopidogrel absorption.
Taubert D; von Beckerath N; Grimberg G; Lazar A; Jung N; Goeser T; Kastrati A; Schömig A; Schömig E
Clin Pharmacol Ther; 2006 Nov; 80(5):486-501. PubMed ID: 17112805
[TBL] [Abstract][Full Text] [Related]
9. C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia.
Hur EH; Lee JH; Lee MJ; Choi SJ; Lee JH; Kang MJ; Seol M; Jang YE; Lee HJ; Kang IS; Shim SK; Ryu SG; Kang YA; Lee YS; Park CJ; Chi HS; Lee KH
Leuk Res; 2008 Oct; 32(10):1601-4. PubMed ID: 18272218
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
[TBL] [Abstract][Full Text] [Related]
11. Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers.
Han Y; Guo D; Chen Y; Tan ZR; Zhou HH
Xenobiotica; 2009 Sep; 39(9):694-9. PubMed ID: 19555315
[TBL] [Abstract][Full Text] [Related]
12. MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists.
Meisel P; Giebel J; Kunert-Keil C; Dazert P; Kroemer HK; Kocher T
Clin Pharmacol Ther; 2006 Jan; 79(1):62-71. PubMed ID: 16413242
[TBL] [Abstract][Full Text] [Related]
13. Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population.
Gümüş-Akay G; Rüstemoğlu A; Karadağ A; Sunguroğlu A
Genet Mol Res; 2008 Oct; 7(4):1193-9. PubMed ID: 19048498
[TBL] [Abstract][Full Text] [Related]
14. Human intestinal P-glycoprotein activity estimated by the model substrate digoxin.
Larsen UL; Hyldahl Olesen L; Guldborg Nyvold C; Eriksen J; Jakobsen P; Østergaard M; Autrup H; Andersen V
Scand J Clin Lab Invest; 2007; 67(2):123-34. PubMed ID: 17365992
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patients.
Foote CJ; Greer W; Kiberd B; Fraser A; Lawen J; Nashan B; Belitsky P
Transplantation; 2007 May; 83(10):1380-4. PubMed ID: 17519790
[TBL] [Abstract][Full Text] [Related]
16. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism.
Shon JH; Yoon YR; Hong WS; Nguyen PM; Lee SS; Choi YG; Cha IJ; Shin JG
Clin Pharmacol Ther; 2005 Aug; 78(2):191-201. PubMed ID: 16084853
[TBL] [Abstract][Full Text] [Related]
17. Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition.
Verstuyft C; Strabach S; El-Morabet H; Kerb R; Brinkmann U; Dubert L; Jaillon P; Funck-Brentano C; Trugnan G; Becquemont L
Clin Pharmacol Ther; 2003 Jan; 73(1):51-60. PubMed ID: 12545143
[TBL] [Abstract][Full Text] [Related]
18. Digoxin pharmacokinetics and MDR1 genetic polymorphisms.
Verstuyft C; Schwab M; Schaeffeler E; Kerb R; Brinkmann U; Jaillon P; Funck-Brentano C; Becquemont L
Eur J Clin Pharmacol; 2003 Apr; 58(12):809-12. PubMed ID: 12698307
[TBL] [Abstract][Full Text] [Related]
19. Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients.
Yasui-Furukori N; Tsuchimine S; Saito M; Nakagami T; Sato Y; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1230-4. PubMed ID: 17559997
[TBL] [Abstract][Full Text] [Related]
20. Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction.
Westphal K; Weinbrenner A; Zschiesche M; Franke G; Knoke M; Oertel R; Fritz P; von Richter O; Warzok R; Hachenberg T; Kauffmann HM; Schrenk D; Terhaag B; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2000 Oct; 68(4):345-55. PubMed ID: 11061574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
